Entrepreneurship of foreign artificial intelligence combined with medical care (full text)

In recent years, artificial intelligence has emerged as a major breakthrough in technology and product-to-public awareness, and it has also attracted a large amount of investment. In March of this year, data from the quantitative analysis company Quid showed that artificial intelligence has attracted more than 20 billion US dollars of investment since 2010. In the past four years, venture capital has grown by an average of 62% per year. By 2020, the global artificial intelligence market will reach 18.3 billion. The US dollar is about RMB 119 billion. The continuous generation and integration of data will provide more and deeper development space for artificial intelligence.

At present, the application of artificial intelligence in the medical industry mainly includes medical diagnosis, auxiliary treatment and health management, and drug development. Artificial intelligence has a natural advantage in improving the efficiency of health care services and the accuracy of disease diagnosis. Under the strong promotion of deep learning algorithms and big data technologies, various advanced applications aiming at improving medical experience and reducing medical costs are being It came into being.

Domestic and foreign capital giants and technology giants are actively deploying artificial intelligence + medical health industry. A large number of startups focused on segmentation are also poised for growth.

Below, we have an overview of the two phases, the inventory of artificial intelligence + medical health startups as of the first half of 2016.

Medical imaging and auxiliary diagnosis

Medical Imaging & Diagnostics

There are a lot of startups investing in medical imaging diagnosis in the world. This is not only due to the high quality of image data, the characteristics of continuous data, the high precision of artificial intelligence technology in image recognition, but also the image diagnosis. The importance of medical decision-making.

Here are a few representative startup companies whose cumulative financing and development directions are as follows:

Monobenzone

Monobenzone can decompose melanin in the skin, and prevent the formation of melanin in the skin, used for the treatment of hyperpigmentation, such as various spots, age spots, melanoma. In addition as intermediates in organic synthesis.

Our company offers variety of products which can meet your multifarious demands.including API Powder.Pharmaceutical Intermediates.Vitamins Powder.Plant Extracts.Food Additive.Peptide Powder and so on We adhere to the management principles of "quality first, customer first and credit-based" since the establishment of the company and always do our best to satisfy potential needs of our customers. Our company is sincerely willing to cooperate with enterprises from all over the world in order to realize a win-win situation since the trend of economic globalization has developed with anirresistible force.

Function:

1.Monobenzone is a compound used as a topical drug for medical depigmentation.

2.The topical application of monobenzone powder in animals decreases the excretion of melanin from melanocytes. The same action is thought to be responsible for the depigmenting effect of the drug in humans.

3.Monobenzone may cause destruction of melanocytes and permanent depigmentation.

4.The histology of the skin after depigmentation with topical monobenzone powder is the same as that seen in vitiligo.

5.The epidermis is normal except for the absence of identifiable melanocytes.

product Photo:

Best Monobenzone,Type 1 3 Collagen,99% Rapamycine Sirolimusa Powder,Hyaluronic Acid Dical

Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptide-nootropic.com